Amarin Corporation plc (AMRN)
USD 0.4
(0.32%)
USD 0.4
(0.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 165.54 Million USD | -16.45% |
| 2022 | 242.48 Million USD | -47.5% |
| 2021 | 461.86 Million USD | -4.3% |
| 2020 | 482.61 Million USD | 44.61% |
| 2019 | 333.73 Million USD | 91.07% |
| 2018 | 174.67 Million USD | 28.29% |
| 2017 | 136.15 Million USD | 42.24% |
| 2016 | 95.72 Million USD | 77.65% |
| 2015 | 53.88 Million USD | 59.8% |
| 2014 | 33.71 Million USD | 133.51% |
| 2013 | 14.43 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 7.36 Million USD | 1373.0% |
| 2006 | 500 Thousand USD | 0.0% |
| 2005 | 500 Thousand USD | -45.05% |
| 2004 | 910 Thousand USD | 120.01% |
| 2003 | -4.54 Million USD | -112.85% |
| 2002 | 35.37 Million USD | 9.47% |
| 2001 | 32.31 Million USD | 162.08% |
| 2000 | 12.33 Million USD | 49.61% |
| 1999 | 8.24 Million USD | -46.13% |
| 1998 | 15.3 Million USD | -28.84% |
| 1997 | 21.5 Million USD | 22.86% |
| 1996 | 17.5 Million USD | -27.69% |
| 1995 | 24.2 Million USD | 29.41% |
| 1994 | 18.7 Million USD | 61.21% |
| 1993 | 11.6 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 16.27 Million USD | -61.3% |
| 2024 Q2 | 42.05 Million USD | 35.12% |
| 2024 Q1 | 31.12 Million USD | -30.49% |
| 2023 Q4 | 44.77 Million USD | 50.14% |
| 2023 Q2 | 42.66 Million USD | -10.97% |
| 2023 FY | 202.58 Million USD | -16.45% |
| 2023 Q3 | 29.82 Million USD | -30.11% |
| 2023 Q1 | 47.92 Million USD | -24.65% |
| 2022 Q1 | 72.39 Million USD | -36.42% |
| 2022 Q2 | 43.63 Million USD | -39.73% |
| 2022 Q4 | 63.6 Million USD | 1.19% |
| 2022 FY | 242.48 Million USD | -47.5% |
| 2022 Q3 | 62.85 Million USD | 44.07% |
| 2021 FY | 461.86 Million USD | -4.3% |
| 2021 Q3 | 111.82 Million USD | -8.59% |
| 2021 Q1 | 113.84 Million USD | -14.07% |
| 2021 Q2 | 122.33 Million USD | 7.46% |
| 2021 Q4 | 113.85 Million USD | 1.81% |
| 2020 Q4 | 132.48 Million USD | 7.34% |
| 2020 FY | 482.61 Million USD | 44.61% |
| 2020 Q3 | 123.42 Million USD | 15.87% |
| 2020 Q2 | 106.52 Million USD | -11.37% |
| 2020 Q1 | 120.18 Million USD | 6.73% |
| 2019 FY | 333.73 Million USD | 91.07% |
| 2019 Q4 | 112.61 Million USD | 29.49% |
| 2019 Q3 | 86.96 Million USD | 11.46% |
| 2019 Q2 | 78.02 Million USD | 38.98% |
| 2019 Q1 | 56.13 Million USD | -6.16% |
| 2018 Q4 | 59.82 Million USD | 43.17% |
| 2018 FY | 174.67 Million USD | 28.29% |
| 2018 Q1 | 33.27 Million USD | -17.72% |
| 2018 Q2 | 39.79 Million USD | 19.61% |
| 2018 Q3 | 41.78 Million USD | 4.99% |
| 2017 Q3 | 35.43 Million USD | 4.73% |
| 2017 Q2 | 33.84 Million USD | 27.99% |
| 2017 FY | 136.15 Million USD | 42.24% |
| 2017 Q1 | 26.43 Million USD | -7.36% |
| 2017 Q4 | 40.43 Million USD | 14.09% |
| 2016 Q4 | 28.54 Million USD | 17.53% |
| 2016 Q3 | 24.28 Million USD | 0.14% |
| 2016 Q2 | 24.25 Million USD | 30.05% |
| 2016 Q1 | 18.64 Million USD | 2.21% |
| 2016 FY | 95.72 Million USD | 77.65% |
| 2015 Q2 | 11.32 Million USD | 9.9% |
| 2015 Q4 | 18.24 Million USD | 30.27% |
| 2015 Q3 | 14 Million USD | 23.65% |
| 2015 Q1 | 10.3 Million USD | -3.07% |
| 2015 FY | 53.88 Million USD | 59.8% |
| 2014 FY | 33.71 Million USD | 133.51% |
| 2014 Q1 | 6.72 Million USD | 11.89% |
| 2014 Q3 | 8.78 Million USD | 15.86% |
| 2014 Q2 | 7.58 Million USD | 12.8% |
| 2014 Q4 | 10.63 Million USD | 21.05% |
| 2013 Q1 | 1.05 Million USD | 0.0% |
| 2013 FY | 14.43 Million USD | 0.0% |
| 2013 Q3 | 4.72 Million USD | 77.75% |
| 2013 Q4 | 6 Million USD | 27.24% |
| 2013 Q2 | 2.65 Million USD | 151.99% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | -100.0% |
| 2008 FY | - USD | -100.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | 7.36 Million USD | 0.0% |
| 2007 FY | 7.36 Million USD | 1373.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2006 Q3 | 100 Thousand USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2006 Q4 | 400 Thousand USD | 300.0% |
| 2006 FY | 500 Thousand USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 100.0% |
| 2005 FY | 500 Thousand USD | -45.05% |
| 2005 Q3 | 250 Thousand USD | 0.0% |
| 2005 Q4 | 250 Thousand USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q4 | -1.6 Million USD | 0.0% |
| 2004 Q1 | 1.04 Million USD | 103.1% |
| 2004 Q2 | 455 Thousand USD | -56.5% |
| 2004 FY | 910 Thousand USD | 120.01% |
| 2003 Q3 | 4.84 Million USD | 217.38% |
| 2003 Q1 | 14.87 Million USD | 6.74% |
| 2003 Q2 | 1.52 Million USD | -89.75% |
| 2003 FY | -4.54 Million USD | -112.85% |
| 2003 Q4 | -33.76 Million USD | -797.62% |
| 2002 Q4 | 13.93 Million USD | -5.96% |
| 2002 Q3 | 14.82 Million USD | 32.11% |
| 2002 Q2 | 11.22 Million USD | -36.28% |
| 2002 Q1 | 17.6 Million USD | 3166.6% |
| 2002 FY | 35.37 Million USD | 9.47% |
| 2001 Q3 | 15.88 Million USD | -5.46% |
| 2001 Q4 | 539 Thousand USD | -96.61% |
| 2001 FY | 32.31 Million USD | 162.08% |
| 2001 Q1 | 5.81 Million USD | 29.52% |
| 2001 Q2 | 16.8 Million USD | 188.76% |
| 2000 Q1 | 4.32 Million USD | 0.0% |
| 2000 Q3 | 5.35 Million USD | 50.0% |
| 2000 Q2 | 3.56 Million USD | -17.48% |
| 2000 Q4 | 4.49 Million USD | -16.07% |
| 2000 FY | 12.33 Million USD | 49.61% |
| 1999 Q1 | 5.1 Million USD | 13.33% |
| 1999 Q3 | 3.3 Million USD | -44.07% |
| 1999 FY | 8.24 Million USD | -46.13% |
| 1999 Q2 | 5.9 Million USD | 15.69% |
| 1998 Q3 | 5.2 Million USD | 13.04% |
| 1998 FY | 15.3 Million USD | -28.84% |
| 1998 Q4 | 4.5 Million USD | -13.46% |
| 1998 Q2 | 4.6 Million USD | 0.0% |
| 1998 Q1 | 4.6 Million USD | -4.17% |
| 1997 Q2 | 6.1 Million USD | 17.31% |
| 1997 FY | 21.5 Million USD | 22.86% |
| 1997 Q1 | 5.2 Million USD | -1.89% |
| 1997 Q4 | 4.8 Million USD | -38.46% |
| 1997 Q3 | 7.8 Million USD | 27.87% |
| 1996 Q3 | 9.1 Million USD | 116.67% |
| 1996 FY | 17.5 Million USD | -27.69% |
| 1996 Q1 | 4.1 Million USD | 0.0% |
| 1996 Q4 | 5.3 Million USD | -41.76% |
| 1996 Q2 | 4.2 Million USD | 2.44% |
| 1995 Q2 | 7.3 Million USD | 0.0% |
| 1995 Q3 | 7.2 Million USD | -1.37% |
| 1995 Q1 | 7.3 Million USD | 0.0% |
| 1995 FY | 24.2 Million USD | 29.41% |
| 1995 Q4 | 4.1 Million USD | -43.06% |
| 1994 Q3 | 13.1 Million USD | 523.81% |
| 1994 Q4 | 7.3 Million USD | -44.27% |
| 1994 FY | 18.7 Million USD | 61.21% |
| 1994 Q1 | 3.1 Million USD | 47.62% |
| 1994 Q2 | 2.1 Million USD | -32.26% |
| 1993 Q2 | 600 Thousand USD | 0.0% |
| 1993 FY | 11.6 Million USD | 0.0% |
| 1993 Q4 | 2.1 Million USD | -83.33% |
| 1993 Q3 | 12.6 Million USD | 2000.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -335.348% |
| Alkermes plc | 1.37 Billion USD | 87.958% |
| Agenus Inc. | 139.61 Million USD | -18.57% |
| Aptorum Group Limited | -1.11 Million USD | 14950.882% |
| Ardelyx, Inc. | 106.66 Million USD | -55.203% |
| Dyadic International, Inc. | 922.95 Thousand USD | -17835.939% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -686.007% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 94779.798% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1339.279% |
| Novavax, Inc. | 639.93 Million USD | 74.132% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 453.426% |
| Pyxis Oncology, Inc. | -2 Million USD | 8377.05% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 32135.275% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -769.301% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 374728.859% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 31511.954% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 268.546% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -20541.022% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 201979.268% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -22.379% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2003.176% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 270.749% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 89.094% |
| AlloVir, Inc. | -398 Thousand USD | 41693.216% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 31.235% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -38942.689% |
| Bicycle Therapeutics plc | -129.52 Million USD | 227.811% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -137850.833% |
| ChromaDex Corporation | 50.78 Million USD | -225.996% |
| Chimerix, Inc. | 324 Thousand USD | -50992.901% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 631.131% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 313.332% |
| CRISPR Therapeutics AG | 240.95 Million USD | 31.298% |
| Precision BioSciences, Inc. | 40.47 Million USD | -309.026% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 268.639% |
| Fortress Biotech, Inc. | 57.85 Million USD | -186.141% |
| Fortress Biotech, Inc. | 57.85 Million USD | -186.141% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -898.619% |
| ImmuCell Corporation | 4.39 Million USD | -3665.476% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 255.99% |
| Immix Biopharma, Inc. | -5468.00 USD | 3027550.622% |
| Incyte Corporation | 3.44 Billion USD | 95.189% |
| Innoviva, Inc. | 261.06 Million USD | 36.59% |
| IO Biotech, Inc. | -756 Thousand USD | 21996.958% |
| Jaguar Health, Inc. | 7.72 Million USD | -2043.203% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 25030.873% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -38.235% |
| ContextLogic Inc. | 59 Million USD | -180.578% |
| MiMedx Group, Inc. | 266.84 Million USD | 37.963% |
| MEI Pharma, Inc. | 49.32 Million USD | -235.599% |
| NextCure, Inc. | -3.68 Million USD | 4593.512% |
| Onconetix, Inc. | -1.12 Million USD | 14786.492% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 671.462% |
| Opthea Limited | 21.72 Thousand USD | -762059.3% |
| Psyence Biomedical Ltd. | -240.00 USD | 68975516.667% |
| Vaxcyte, Inc. | -75 Million USD | 320.721% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 288871.238% |
| Precigen, Inc. | 106 Thousand USD | -156070.755% |
| Pharming Group N.V. | 220.1 Million USD | 24.79% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -32043.883% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -16306.442% |
| PureTech Health plc | -1.6 Million USD | 10426.949% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -50.804% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 191.253% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 465.231% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 852.904% |
| Acelyrin, Inc. | -115 Thousand USD | 144048.696% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1647110.248% |
| Summit Therapeutics Inc. | -2.05 Million USD | 8175.171% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 29091.419% |
| Senti Biosciences, Inc. | -2.68 Million USD | 6269.996% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3986.423% |
| Elevation Oncology, Inc. | -39 Thousand USD | 424564.103% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3550.208% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 4299.365% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -468.303% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -33275.202% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 301083.636% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -59.023% |
| Seer, Inc. | 7.02 Million USD | -2255.785% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3681.201% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -668.35% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 139807.657% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 115619.78% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -27082.43% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -37.408% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 47.225% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 3310920.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -6331.274% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 326353.449% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -463.314% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 71453.879% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 33746.545% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2432.22% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 34984.152% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1591840.385% |
| Soligenix, Inc. | 97.31 Thousand USD | -170015.403% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1631.511% |
| Kura Oncology, Inc. | -849 Thousand USD | 19598.351% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 346.693% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 112712.925% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -67.147% |
| Autolus Therapeutics plc | -4.86 Million USD | 3501.294% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -299.993% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 98636.31% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -74.763% |
| GRI Bio, Inc. | 10.84 Million USD | -1426.99% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -6417.398% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2005.618% |
| IGM Biosciences, Inc. | -211.66 Million USD | 178.211% |
| INmune Bio, Inc. | 155 Thousand USD | -106700.645% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -167.265% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 11089.975% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 25628.565% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 565588.146% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -41079.353% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 8393.637% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 52988.498% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -75.248% |
| Verastem, Inc. | -62 Thousand USD | 267101.613% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -6698.398% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 63525.67% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -5368.814% |
| Histogen Inc. | 3.76 Million USD | -4292.173% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -28630.828% |
| Surrozen, Inc. | -27.23 Million USD | 707.936% |
| Organovo Holdings, Inc. | -5.38 Million USD | 3171.832% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 13839.211% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 745.46% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -725.559% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 8360756.566% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2628.807% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 246693.973% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -6.945% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -113439.781% |
| Apollomics, Inc. | 127 Thousand USD | -130247.244% |
| Mesoblast Limited | -9.81 Million USD | 1786.612% |
| Turnstone Biologics Corp. | 16.5 Million USD | -902.914% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 249.826% |
| Synaptogenix, Inc. | -6347.00 USD | 2608277.092% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 324690.196% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -2.588% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 90.582% |
| Better Therapeutics, Inc. | -2.72 Million USD | 6165.995% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 247.592% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 51.035% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1451195.722% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2744.425% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 15040.523% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2162.107% |
| Insmed Incorporated | 239.63 Million USD | 30.92% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -4526.635% |
| OmniAb, Inc. | 14.66 Million USD | -1028.663% |
| Alector, Inc. | -95.05 Million USD | 274.157% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -31.778% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 480.878% |
| Zai Lab Limited | 170.9 Million USD | 3.137% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -102.183% |
| Aura Biosciences, Inc. | -1.29 Million USD | 12883.089% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -127239.231% |
| Immunic, Inc. | -111 Thousand USD | 149236.036% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -944.159% |
| Veracyte, Inc. | 248.14 Million USD | 33.289% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 102.369% |
| FibroGen, Inc. | 128.9 Million USD | -28.422% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 29351341.135% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1518.896% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 95.129% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -42455.527% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 53.414% |
| TG Therapeutics, Inc. | 219.1 Million USD | 24.448% |
| Galecto, Inc. | -830 Thousand USD | 20044.699% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 12052.419% |
| Fortrea Holdings Inc. | 424 Million USD | 60.957% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 292.116% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 29295.944% |
| XBiotech Inc. | -1.74 Million USD | 9592.03% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 15040.523% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 456.224% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 319.161% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -125.523% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -885.187% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 57.449% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 433.436% |
| Vaxxinity, Inc. | -2.23 Million USD | 7510.072% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 49.337% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1561.88% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -577.032% |
| NexImmune, Inc. | -1.02 Million USD | 16250.783% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -3065474.074% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2429.707% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.535% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 247815.744% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 4761.814% |
| Ainos, Inc. | -253.73 Thousand USD | 65342.203% |
| Pluri Inc. | 322 Thousand USD | -51310.248% |
| Prothena Corporation plc | -129.2 Million USD | 228.127% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -228.298% |
| Celularity Inc. | 6.75 Million USD | -2350.644% |
| Rallybio Corporation | -150 Thousand USD | 110460.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 607.685% |
| MeiraGTx Holdings plc | 287 Thousand USD | -57579.791% |
| Omeros Corporation | -69.77 Million USD | 337.236% |
| Humacyte, Inc. | -76.55 Million USD | 316.252% |
| Immunocore Holdings plc | 248.39 Million USD | 33.355% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1191.311% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -165.367% |
| Blueprint Medicines Corporation | 236.58 Million USD | 30.029% |
| CalciMedica, Inc. | -58 Thousand USD | 285515.517% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 11708.766% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -469.75% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 5920.71% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 636.339% |
| Pulmatrix, Inc. | -8.22 Million USD | 2113.881% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 14248.803% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 41588.972% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 141.51% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -5864.184% |
| Cytokinetics, Incorporated | -322.59 Million USD | 151.316% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -19101.953% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 48645.748% |
| Vor Biopharma Inc. | -3.49 Million USD | 4840.578% |
| Roivant Sciences Ltd. | 109.23 Million USD | -51.546% |
| Evogene Ltd. | 1.39 Million USD | -11732.809% |
| ProKidney Corp. | -3.16 Million USD | 5323.761% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 476.984% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -2314.19% |
| CorMedix Inc. | -205.56 Thousand USD | 80630.935% |
| BioLineRx Ltd. | 1.1 Million USD | -14840.523% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 310.422% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 501739.394% |
| Atai Life Sciences N.V. | -5000.00 USD | 3310920.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 135946.347% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 172538.542% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 12017.999% |
| Sagimet Biosciences Inc. | 2 Million USD | -8177.05% |
| MediciNova, Inc. | 979.7 Thousand USD | -16797.025% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 296.327% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 175173.767% |
| GeoVax Labs, Inc. | -20.72 Million USD | 898.914% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 32.304% |
| Biomea Fusion, Inc. | -4.2 Million USD | 4040.514% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 81.023% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2129.208% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 53500.323% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1379608.333% |
| Absci Corporation | -41.84 Million USD | 495.567% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3310920.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 316.753% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 6826.575% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 22.548% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 17692.03% |
| Allakos Inc. | -6.14 Million USD | 2795.668% |
| Imunon, Inc. | -720 Thousand USD | 23091.646% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 339.928% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 65.215% |
| BioAtla, Inc. | -103.73 Million USD | 259.587% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1451195.722% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 93100.562% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 168.175% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 53328.617% |
| XOMA Corporation | 3.86 Million USD | -4187.516% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 336.2% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1018.974% |
| aTyr Pharma, Inc. | -2.38 Million USD | 7032.203% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1228.579% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 570931.034% |
| Viridian Therapeutics, Inc. | -1 Million USD | 16522.718% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1273392207.692% |
| Akari Therapeutics, Plc | -4000.00 USD | 4138625.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 74.008% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -84920.133% |
| UroGen Pharma Ltd. | 73.35 Million USD | -125.68% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 720.143% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1425748.407% |
| Orgenesis Inc. | -5.72 Million USD | 2991.546% |
| Entera Bio Ltd. | -56 Thousand USD | 295708.929% |
| GH Research PLC | -315 Thousand USD | 52652.698% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 87687.831% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 31631.619% |
| Xencor, Inc. | -85.26 Million USD | 294.16% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 75013.226% |
| Replimune Group, Inc. | -2.65 Million USD | 6335.066% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 16633.664% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 6.918% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -84920.133% |
| Portage Biotech Inc. | -54 Thousand USD | 306657.407% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 175173.767% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 44010.08% |
| OncoCyte Corporation | 413 Thousand USD | -39982.567% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3682880.868% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 74568118.018% |
| Purple Biotech Ltd. | -196 Thousand USD | 84559.694% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1745.908% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1592.302% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1684.889% |
| HilleVax, Inc. | -2.15 Million USD | 7778.154% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 170760.825% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1103412.45% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 24881.587% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 719843.478% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2205501.963% |
| Savara Inc. | -44.26 Million USD | 474.003% |
| Curis, Inc. | 9.81 Million USD | -1587.3% |
| Daré Bioscience, Inc. | 2.76 Million USD | -5877.241% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 132757.788% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 9674.378% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 72705.702% |
| BeiGene, Ltd. | 2.07 Billion USD | 92.037% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 6020.848% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 141.42% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -192.021% |
| Erasca, Inc. | -3.73 Million USD | 4535.718% |
| bluebird bio, Inc. | -4.03 Million USD | 4207.717% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 586750.365% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 91.307% |
| DBV Technologies S.A. | 15.72 Million USD | -952.524% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 586750.365% |
| Moderna, Inc. | 2.15 Billion USD | 92.318% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 18191.913% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1967.712% |
| Molecular Templates, Inc. | 50.39 Million USD | -228.487% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 30984.515% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -23.734% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2760.575% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 520.764% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 248.964% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 4713.74% |
| MacroGenics, Inc. | 50.52 Million USD | -227.629% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2814.677% |
| Prime Medicine, Inc. | -147.9 Million USD | 211.924% |
| Aditxt, Inc. | -111.66 Thousand USD | 148354.523% |
| Adagene Inc. | 18.11 Million USD | -814.011% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -33822.336% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -18.073% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -4.882% |
| SciSparc Ltd. | 2.19 Million USD | -7438.297% |
| Vericel Corporation | 135.57 Million USD | -22.102% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 660968.697% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 534413.472% |
| Generation Bio Co. | -73.91 Million USD | 323.973% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 37981.236% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -203.083% |
| Invivyd, Inc. | -2.02 Million USD | 8262.771% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 155.026% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 160138.864% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -71.78% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -68.424% |
| ADMA Biologics, Inc. | 88.21 Million USD | -87.65% |
| Clene Inc. | 533 Thousand USD | -30958.349% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -586.63% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 17397.91% |
| GeoVax Labs, Inc. | -20.72 Million USD | 898.914% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -8227.012% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 85291.647% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -232.378% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 2434.193% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 19901.555% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -98.455% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -226321.107% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -211.39% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 195.585% |
| Trevena, Inc. | 1.45 Million USD | -11277.388% |
| Surrozen, Inc. | -27.23 Million USD | 707.936% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 46995.467% |
| Cingulate Inc. | -582.91 Thousand USD | 28498.677% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 534103.226% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 940.352% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2186903.17% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 18890.125% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 75.681% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 16855.162% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 293914.561% |
| Kronos Bio, Inc. | 1.37 Million USD | -11965.671% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 408.465% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 56792.123% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 34000.523% |
| ImmunityBio, Inc. | -17.89 Million USD | 1025.327% |
| Korro Bio, Inc. | -3.63 Million USD | 4660.358% |
| Kineta, Inc. | 5.43 Million USD | -2946.954% |
| BioVie Inc. | -229.37 Thousand USD | 72269.834% |
| Codexis, Inc. | 57.33 Million USD | -188.731% |
| Celularity Inc. | 6.75 Million USD | -2350.644% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -4025.118% |
| Celcuity Inc. | -142.77 Thousand USD | 116047.805% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -327120.795% |
| Cibus, Inc. | 1.42 Million USD | -11541.421% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 44362.299% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 822.287% |
| IN8bio, Inc. | -2.5 Million USD | 6718.992% |
| Kodiak Sciences Inc. | -25.94 Million USD | 737.997% |
| Annexon, Inc. | -3.26 Million USD | 5167.065% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 8198.875% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 496.629% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -25765.781% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 78.736% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 4.287% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 8812.684% |
| Arcellx, Inc. | 108.27 Million USD | -52.884% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 611.418% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -109.006% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 882.626% |
| Moolec Science SA | -143.3 Thousand USD | 115616.556% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 491.183% |
| Geron Corporation | -123.5 Million USD | 234.038% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -4936.234% |
| Royalty Pharma plc | 1.79 Billion USD | 90.772% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 336.183% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 4583184.164% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -71441.676% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 248.582% |
| Humacyte, Inc. | -76.55 Million USD | 316.252% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 17540.533% |
| 89bio, Inc. | -273 Thousand USD | 60737.729% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 13269.531% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 19621.344% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 134686.179% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -14693.655% |
| Notable Labs, Ltd. | 113 Thousand USD | -146396.46% |
| Liquidia Corporation | 14.6 Million USD | -1033.842% |
| Mustang Bio, Inc. | -2.22 Million USD | 7540.045% |
| Immunovant, Inc. | -231 Thousand USD | 71762.771% |
| Quantum-Si incorporated | 488 Thousand USD | -33822.336% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 397.955% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 551903.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -8790.494% |
| Acasti Pharma Inc. | -11 Thousand USD | 1505018.182% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 81002.858% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 25628.565% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 198.823% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -14490.509% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 43549.081% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 8554.597% |
| PepGen Inc. | -1.18 Million USD | 14081.503% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 130447.244% |
| United Therapeutics Corporation | 2.07 Billion USD | 92.003% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 822.981% |
| Solid Biosciences Inc. | -76.56 Million USD | 316.215% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 200554.089% |
| Immuneering Corporation | -764.13 Thousand USD | 21763.757% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -249720.415% |
| Belite Bio, Inc | -399 Thousand USD | 41588.972% |
| XOMA Corporation | 3.86 Million USD | -4187.516% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 926.218% |
| Bionomics Limited | -434.44 Thousand USD | 38203.667% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 15513.501% |
| uniQure N.V. | 2.21 Million USD | -7373.634% |
| Cassava Sciences, Inc. | -89.42 Million USD | 285.121% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 279.801% |
| Forte Biosciences, Inc. | -9000.00 USD | 1839444.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 19925.269% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 37981.236% |
| Altimmune, Inc. | -65.37 Million USD | 353.225% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 54.274% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 15513.501% |
| Compugen Ltd. | 31.45 Million USD | -426.279% |
| Peak Bio, Inc. | 367.76 Thousand USD | -44912.222% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -575.237% |
| Benitec Biopharma Inc. | 108 Thousand USD | -153178.704% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 212332.051% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 13860.682% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 9185.675% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 139210.084% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 13860.682% |
| Instil Bio, Inc. | -4.75 Million USD | 3580.677% |
| argenx SE | 1.1 Billion USD | 85.066% |
| Immunome, Inc. | -8.9 Million USD | 1958.549% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 8858.783% |
| Verona Pharma plc | -679.62 Thousand USD | 24457.733% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 94694.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 7040.922% |
| CervoMed Inc. | -1.29 Million USD | 12896.656% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 6977.482% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3565.376% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -6599.352% |
| Moolec Science SA | -143.3 Thousand USD | 115616.556% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 40670.791% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 6296.491% |
| AnaptysBio, Inc. | 14.78 Million USD | -1019.958% |
| Design Therapeutics, Inc. | -537 Thousand USD | 30927.002% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 38868.384% |
| NeurAxis, Inc. | 2.15 Million USD | -7575.648% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -7613.933% |
| Lumos Pharma, Inc. | 2 Million USD | -8148.181% |
| Achilles Therapeutics plc | -4.73 Million USD | 3598.873% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 94694.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 156751.053% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -422.892% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -19101.953% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 16140.795% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 463.443% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -384879.07% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 20238.808% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1258201.535% |
| Palisade Bio, Inc. | 246 Thousand USD | -67193.089% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 501739.394% |
| Beam Therapeutics Inc. | -59.67 Million USD | 377.418% |
| Neurogene Inc. | -3.26 Million USD | 5174.831% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -18.808% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 4583.776% |
| Sesen Bio, Inc. | 40 Million USD | -313.853% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 55837.71% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 4210.739% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1830.514% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1075.717% |
| Athira Pharma, Inc. | -969 Thousand USD | 17183.695% |
| Vaccinex, Inc. | -16 Million USD | 1134.373% |
| HCW Biologics Inc. | -574.82 Thousand USD | 28898.554% |
| XOMA Corporation | 3.86 Million USD | -4187.516% |
| Nektar Therapeutics | 53.47 Million USD | -209.55% |
| Arvinas, Inc. | 71.8 Million USD | -130.558% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 298.345% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 363.705% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 51510.248% |
| Rezolute, Inc. | -36 Thousand USD | 459936.111% |
| Clene Inc. | 533 Thousand USD | -30958.349% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 12892701.246% |
| BeyondSpring Inc. | 1.75 Million USD | -9354.083% |
| Synlogic, Inc. | -1.92 Million USD | 8704.002% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 447508.108% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2714.356% |
| Peak Bio, Inc. | 367.76 Thousand USD | -44912.222% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 972.968% |
| Krystal Biotech, Inc. | 47.6 Million USD | -247.739% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -17.329% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -3194.348% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 6493.472% |
| MannKind Corporation | 136.19 Million USD | -21.551% |
| Ikena Oncology, Inc. | -50.49 Million USD | 427.856% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -52.132% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3875.165% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 65790.873% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 3310920.0% |
| Legend Biotech Corporation | 140.92 Million USD | -17.464% |
| Mural Oncology plc | -2.56 Million USD | 6548.812% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 30143.739% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 165641.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -697.634% |
| REGENXBIO Inc. | 53.02 Million USD | -212.171% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 3190.208% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 86151.202% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 9657.794% |
| Vaxart, Inc. | -60.76 Million USD | 372.437% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 63096.042% |
| Cellectis S.A. | 18 Thousand USD | -919572.222% |
| Longeveron Inc. | 221 Thousand USD | -74805.43% |
| Repare Therapeutics Inc. | -80.07 Million USD | 306.745% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 84.854% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 12892.968% |
| Revolution Medicines, Inc. | -399.66 Million USD | 141.42% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 473074.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -337738.776% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.077% |
| Denali Therapeutics Inc. | -93.34 Million USD | 277.343% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 660968.697% |
| Veru Inc. | 7.56 Million USD | -2087.98% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 109729.801% |
| Cingulate Inc. | -582.91 Thousand USD | 28498.677% |
| Passage Bio, Inc. | -3.72 Million USD | 4548.831% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1374568.615% |
| Exicure, Inc. | -1.42 Million USD | 11733.24% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 43322.193% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -6024.343% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 32389.657% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -142.992% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 110750.571% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 379.602% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -42237.852% |
| OmniAb, Inc. | 14.66 Million USD | -1028.663% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -727.995% |
| Lipocine Inc. | -2.85 Million USD | 5906.789% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 9082.149% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 3001.683% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 11089.975% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -119.795% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 254778.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -96.381% |
| Ocugen, Inc. | -33.53 Million USD | 593.607% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 5335.326% |
| Q32 Bio Inc. | 578 Thousand USD | -28540.311% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 62568.302% |
| Alumis Inc. Common Stock | -1.28 Million USD | 12992.601% |
| Equillium, Inc. | 35.95 Million USD | -360.373% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 9797.774% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -32963.3% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 4004478.326% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 64015.444% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -39061.651% |
| Dominari Holdings Inc. | 2.03 Million USD | -8018.735% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 90327.338% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1317.661% |
| Bio-Techne Corporation | 773.07 Million USD | 78.587% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -855.835% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 64.074% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 14260.907% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 790.329% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1315.243% |
| Nkarta, Inc. | -5.86 Million USD | 2920.6% |
| BioCardia, Inc. | -7.24 Million USD | 2383.639% |
| Iterum Therapeutics plc | -1.75 Million USD | 9559.486% |